Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

3 Hot Biotech Bets, Right Now!
CNBC
Saturday, September 12, 2009 - 10:29am
tags:
Genzyme, Gilead Sciences, Amgen
Osiris CFO leaves after failure of stem-cell drug
Yahoo/AP
Saturday, September 12, 2009 - 10:19am
tags:
Osiris, stem cells
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
PR NewsWire
Saturday, September 12, 2009 - 10:18am
tags:
Regeneron, Aflibercept, pancreatic cancer
Merck gains on Fosamax ruling
MarketWatch
Saturday, September 12, 2009 - 10:17am
tags:
Merck, Fosamax
Judge declares mistrial in first Fosamax trial
Yahoo/AP
Saturday, September 12, 2009 - 10:15am
tags:
Fosamax, Merck
Nycomed Said to Be Close to Getting Debt Funding for Solvay Bid
Bloomberg
Friday, September 11, 2009 - 9:23am
tags:
Nycomed, Solvay, M&A
Merck KGaA pulls ahead in hot oral MS drug race
Fierce Biotech
Friday, September 11, 2009 - 9:21am
tags:
Merck KGaA, multiple sclerosis, MS
Taking Profits from Swine Flu with Tamiflu
Seeking Alpha
Friday, September 11, 2009 - 8:58am
tags:
Tamiflu, swine flu, Gilead Sciences
Discovery Labs-FDA meeting set for Sept. 29
Bizjournals.com
Friday, September 11, 2009 - 8:56am
tags:
FDA, Discovery Labs, Surfaxin
ZymoGenetics’ rheumatoid arthritis drug test goes poorly
Bizjournals.com
Friday, September 11, 2009 - 8:50am
tags:
ZymoGenetics, rheumatoid arthritis, atacicept, Merck Serono
GSK is in talks on patent pools
Guardian, UK
Friday, September 11, 2009 - 8:48am
tags:
GSK, HIV, patents
Almirall Jumpstarts COPD Hopeful Aclidinium
InVivo
Friday, September 11, 2009 - 8:46am
tags:
Almirall, COPD, Eklira
Reports: Dr. Reddy's not seeking to sell stake
Marketwatch
Friday, September 11, 2009 - 8:45am
tags:
M&A, Dr Reddy's, GSK
Amylin and Biocon say they will work together to develop diabetes drug combining 2 hormones
Yahoo/AP
Friday, September 11, 2009 - 8:23am
tags:
Amylin, Biocon, partnerships, diabetes
Shire Set for $50 Million Windfall on Demand for Gaucher Drug
Bloomberg
Friday, September 11, 2009 - 8:21am
tags:
Shire, Genzyme, Gaucher disease
Vivus: A One Trick Pony
Seeking Alpha
Friday, September 11, 2009 - 8:19am
tags:
Vivus, Arena Pharmaceuticals, Orexigen, obesity, Qnexa
Eli Lilly cites reduction in chronic lower back pain in Cymbalta study
Yahoo/AP
Friday, September 11, 2009 - 8:19am
tags:
Eli Lilly, Cymbalta, back pain, chronic pain
Another Positive Indication for Amgen's Denosumab
Seeking Alpha
Friday, September 11, 2009 - 6:01am
tags:
Amgen, denosumab, Novartis, rheumatoid arthritis
GlaxoSmithKline to Defend Paxil in Birth Defect Test-Case Trial
Bloomberg
Friday, September 11, 2009 - 6:00am
tags:
GSK, antidepressants, Paxil, lawsuits, birth defects
Glaxo's U.S. Cervarix Approval More Important for Company's Pride than for Sales
Seeking Alpha
Friday, September 11, 2009 - 5:59am
tags:
GSK, Cervarix, Merck, Gardasil, HPV, vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.